Intravitreal Anti-VEGF injection in recurrent vitreous hemorrhage in Eale’s disease: A case report
Article Information
Publication Timeline
- Received20 January 2024
- Accepted10 February 2024
Abstract
Study design: case report
Purpose: to evaluate the efficacy of intravitreal bevacizumab in vitreous hemorrhage in Eales' disease
Methods: A 37year old male patient presented to our out-patient department in Manjunatha Eye hospital, Kundapura, Udupi district with sudden diminution of vision in his right eye since 1month. He was found to have a vision of hand movements in Right eye His fundus examination revealed dense vitreous hemorrhage with supero-temporal quadrant showing yellowish retinal patch with irregular margins suggestive of retinitis, and peripheral retinal vessels showing signs of vasculitits. All investigations were negative. He was given three intravitreal injection bevacizumab1.25mg in 0.05ml on monthly basis.
Results: patient improved to 6/6 vision by the end of 3months without increase in IOP
Conclusion: Intravitreal bevacizumab injections effectively resolves the vitreous hemorrhage in Eales’ disease thereby avoiding the surgical intervention.
References
- Biswas J, Ravi RK, Naryanasamy A, Kulandai LT, Madhavan HN. Eales' disease - current concepts in diagnosis and management. Journal of Ophthalmic Inflammation and Infection. 2013;3(1):11. [Google Scholar][Crossref]
- Khan MN, Raza SS, Qadir S, Rehman H, Hussain AK, Nadeem MD, Ullah F. Eales Disease. Journal of Ayub Medical College Abbottabad. 2016;28(4):816-7. [Google Scholar][Crossref]
- Biswas J, Ravi RK, Naryanaswamy A, Kulandai LT, Madhavan HN. Eales' disease: current concepts in diagnosis and management. Journal of Ophthalmic Inflammation and Infection. 2013;3(1):11. [Google Scholar][Crossref]
- Patwardhan SD, Azad R, Shah BM, Sharma Y. Role of intravitreal bevacizumab in Eales' disease with dense vitreous hemorrhage: a prospective randomized control study. Retina. 2011;31:866-70. [Google Scholar][Crossref]
- Chanana B, Azaad RV, Patwardhan S. Role of bevacizumab in the management of Eales' disease. International Ophthalmology. 2010;30:57-61. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]
How to Cite
K, S. (2024). Intravitreal Anti-VEGF injection in recurrent vitreous hemorrhage in Eale’s disease: A case report. International Journal of Medical and All Body Health Research, 5(1), 17-18.
K, Shruthi. "Intravitreal Anti-VEGF injection in recurrent vitreous hemorrhage in Eale’s disease: A case report." International Journal of Medical and All Body Health Research, vol. 5, no. 1, 2024, pp. 17-18.
K, S. (2024) 'Intravitreal Anti-VEGF injection in recurrent vitreous hemorrhage in Eale’s disease: A case report', International Journal of Medical and All Body Health Research, 5(1), pp. 17-18.
K S. Intravitreal Anti-VEGF injection in recurrent vitreous hemorrhage in Eale’s disease: A case report. International Journal of Medical and All Body Health Research. 2024;5(1):17-18.
Similar Articles
- Study of Blood Transfusion Practices in Obstetric Patients at a Tertiary Care Centre Vol 6, Issue 3 (2025)
- Prevalence of cytomegalovirus in new and recurrent ulcerative colitis Vol 4, Issue 3 (2023)
- Rhinolith misdiagnosed as recurrent sinusitis Vol 3, Issue 2 (2022)
- Behcet’s disease presenting as recurrent ocular oral and scrotal lesions in a young man Vol 3, Issue 1 (2022)
- Hypertensive supratentorial intracerebral hemorrhage: Surgery or conservative management? Vol 1, Issue 3 (2020)
Find this Article on
Google Scholar Semantic Scholar OpenAlex ResearchGate BASEA newly published article may take a few days to appear on these services.